Exact Mass: 495.13833160000013
Exact Mass Matches: 495.13833160000013
Found 75 metabolites which its exact mass value is equals to given mass value 495.13833160000013
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Sodium folinate
C20H22N7NaO7 (495.14783420000003)
V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AF - Detoxifying agents for antineoplastic treatment
3-Azetidinecarboxamide, 1-(7-(2-chlorophenyl)-8-(4-chlorophenyl)-2-methylpyrazolo(1,5-a)-1,3,5-triazin-4-yl)-3-(ethylamino)-
N-(2-beta-D-glucopyranosyl-5-hydroxysalicyl)-5-hydroxy-6-methoxyanthranilic acid methyl ester
Cys Asp Met Gln
Cys Asp Gln Met
Cys Glu Met Asn
Cys Glu Asn Met
Cys Met Asp Gln
Cys Met Glu Asn
Cys Met Asn Glu
Cys Met Gln Asp
Cys Asn Glu Met
Cys Asn Met Glu
Cys Gln Asp Met
Cys Gln Met Asp
Asp Cys Met Gln
Asp Cys Gln Met
Asp Met Cys Gln
Asp Met Gln Cys
Asp Gln Cys Met
Asp Gln Met Cys
Glu Cys Met Asn
Glu Cys Asn Met
Glu Met Cys Asn
Glu Met Asn Cys
Glu Asn Cys Met
Glu Asn Met Cys
Met Cys Asp Gln
Met Cys Glu Asn
Met Cys Asn Glu
Met Cys Gln Asp
Met Asp Cys Gln
Met Asp Gln Cys
Met Glu Cys Asn
Met Glu Asn Cys
Met Asn Cys Glu
Met Asn Glu Cys
Met Gln Cys Asp
Met Gln Asp Cys
Asn Cys Glu Met
Asn Cys Met Glu
Asn Glu Cys Met
Asn Glu Met Cys
Asn Met Cys Glu
Asn Met Glu Cys
Gln Cys Asp Met
Gln Cys Met Asp
Gln Asp Cys Met
Gln Asp Met Cys
Gln Met Cys Asp
Gln Met Asp Cys
(R)-4-tert-Butyl-2-[(R)-2-(bis(1-phenyl)-phosphino)ferrocen-1-yl]oxazoline
2-chloro-N-(2,3-dihydro-1H-inden-5-yl)-5-[(4-phenyl-1-piperazinyl)sulfonyl]benzamide
C26H26ClN3O3S (495.13833160000013)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
methyl (1S,9R,10R,11R)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
methyl (1R,9S,10S,11S)-10-(hydroxymethyl)-12-(2-methylphenyl)sulfonyl-6-oxo-5-pyridin-3-yl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
C25H25N3O6S (495.14639900000003)
3-[4-[(1S,5R)-3-(3-chlorophenyl)sulfonyl-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]-N,N-dimethylbenzamide
C26H26ClN3O3S (495.13833160000013)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
N-[(3,4-dichlorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]acetamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
3,5-dichloro-N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(4-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]benzamide
C23H27Cl2N3O5 (495.13276720000005)
IPI-9119
IPI-9119 is an orally active, selective and irreversible FASN inhibitor with an IC50 of 0.3 nM in vitro biochemical assay. IPI-9119 inhibits tumor growth of castration-resistant prostate cancer (CRPC) xenografts mouse models[1][2].